RevCycleAI Brief
Published researchXpertDox announced a $20 million Series A on November 11, 2026, led by Savant Growth, with funding from Savant's investment partner, Kennet Partners. Javier Rojas, co-founder and managing partner of Savant Growth, joined the board. The company says XpertCoding codes more than 91% of claims it receives without manual intervention, returns them in under 24 hours, and keeps coding-related denials below 2%; that revenue doubled over the last 12 months with 126% net revenue retention and 95% customer retention; and that it serves seven FQHCs across six states. Those operating figures are company-reported. No valuation was disclosed, and no revenue dollar or total capital raised was printed. The release says the product is live on eClinicalWorks, athenahealth, Epic, NextGen, and other EHRs.
✦ Ask RevCycleAI about XpertDox
Pro AI analystGo deeper on competitors, positioning, buyers, funding and market signals.
Unlock Ask RevCycleAI →RevCycleAI Intelligence Scores
MethodologyMarket Matrix: Emerging · Impact 27 · Capability 14
Funding & transaction history
1 trackedXpertDox announced a $20 million Series A on November 11, 2026, led by Savant Growth, with funding from Savant's investment partner, Kennet Partners. Javier Rojas, co-founder and managing partner of Savant Growth, joined the board. The company says XpertCoding codes more than 91% of claims it receives without manual intervention, returns them in under 24 hours, and keeps coding-related denials below 2%; that revenue doubled over the last 12 months with 126% net revenue retention and 95% customer retention; and that it serves seven FQHCs across six states. Those operating figures are company-reported. No valuation was disclosed, and no revenue dollar or total capital raised was printed. The release says the product is live on eClinicalWorks, athenahealth, Epic, NextGen, and other EHRs.